These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6606065)

  • 1. Transfer factor in restoration of cell mediated immunity in lung cancer patients.
    Fujisawa T; Yamaguchi Y; Kimura H
    Jpn J Surg; 1983 Jul; 13(4):304-11. PubMed ID: 6606065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immunity: correlation of mixed-leucocyte-macrophage migration inhibition with delayed-type hypersensitivity after immunization and donor-specific transfer of cell migration inhibition by dialyzable leucocyte extract.
    Mazaheri R; Hamblin AS; Zuckerman AJ
    Cell Immunol; 1983 Nov; 82(1):147-62. PubMed ID: 6196129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfer of delayed type hypersensitivity in guinea pigs].
    Smogorzewska E
    Probl Med Wieku Rozwoj; 1990; 16():167-88. PubMed ID: 2152405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
    Catalona WJ; Tarpley JL; Potvin C; Chretien PB
    Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human specific transfer factor to Staphylococcus aureus antigens].
    Liubchenko TA; Holeva OH; Kholodna LS; Stepanchuk VA; Vershyhora AIu
    Fiziol Zh (1994); 1997; 43(3-4):25-32. PubMed ID: 9303798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of transfer factor on the immunity state of patients with bronchopulmonary cancer. A report on 12 cases (author's transl)].
    Hainaut J; Challan-Belval P; Haguenauer G; Pellegrin J; Allard P; Kermarec J
    Ann Med Interne (Paris); 1979; 130(11):517-21. PubMed ID: 317697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific and aspecific immune responsiveness in lung cancer patients: cutaneous delayed hypersensitivity reactions to a lung cancer-associated antigen.
    Sega E; Mottolese M; Cordiali-Fei P; Citro G; Colizza S; Alcione A; Di Paola M
    J Surg Oncol; 1980; 14(4):315-25. PubMed ID: 6160358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI).
    Tsang PH; Roboz JP; Holland JF; Bekesi JG
    Immunol Lett; 1988 Jan; 17(1):63-70. PubMed ID: 3280478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunization.
    Disis ML; Schiffman K; Gooley TA; McNeel DG; Rinn K; Knutson KL
    Clin Cancer Res; 2000 Apr; 6(4):1347-50. PubMed ID: 10778962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis.
    Fabre RA; Pérez TM; Aguilar LD; Rangel MJ; Estrada-Garcìa I; Hernández-Pando R; Estrada Parra S
    Clin Exp Immunol; 2004 May; 136(2):215-23. PubMed ID: 15086383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer factor in chronic mucocutaneous candidiasis.
    Masi M; De Vinci C; Baricordi OR
    Biotherapy; 1996; 9(1-3):97-103. PubMed ID: 8993766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of coccidioidomycosis.
    Catanzaro A; Spitler L; Moser KM
    J Clin Invest; 1974 Sep; 54(3):690-701. PubMed ID: 4604574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of the transfer factor in transplantation immunology].
    Sakharov PP; Kudrina GP
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Apr; (4):13-6. PubMed ID: 375633
    [No Abstract]   [Full Text] [Related]  

  • 14. Separate transfer of mouse protection and delayed-type hypersensitivity with Salmonella typhimurium transfer factor.
    Kita E; Matsuda Y; Matsuda K; Kashiba S
    Cell Immunol; 1984 Sep; 87(2):528-37. PubMed ID: 6380767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of T-lymphocyte deficiency with dialysable leucocyte extract.
    Valdimarsson H; Hambleton G; Henry K; McConnell I
    Clin Exp Immunol; 1974 Feb; 16(2):141-52. PubMed ID: 4549704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nature and activities of transfer factor.
    Petersen EA; Kirkpatrick CH
    Ann N Y Acad Sci; 1979; 332():216-27. PubMed ID: 231399
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence.
    Kopersztych S; Rezkallah MT; Miki SS; Naspitz CK; Mendes NF
    Cancer; 1976 Sep; 38(3):1149-54. PubMed ID: 1085193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell mediated immunity in patients with Virchowian hanseniasis before and after treatment with transfer factor.
    Leser PG; Margarido L; Belda W; Sartori SG; Hares WA; Freire CA; Fleury R; Montenegro MR; Leser W; Naspitz CK
    Hansenol Int; 1980 Jun; 5(1):3-27. PubMed ID: 7042563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of cell-mediated immunity with cell-free leukocyte extracts. II. Demonstration of antigen-specific and nonspecific components.
    Croft S; Edwards JM; Basten A
    Cell Immunol; 1980 Dec; 56(2):427-39. PubMed ID: 6970628
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of active T lymphocytes in the peripheral blood by the AE rosette test. Correlation of the AE and E rosette tests with lymphocyte reactivity in vitro after PHA stimulation].
    Karwowska W; Kunicka A
    Probl Med Wieku Rozwoj; 1982; 11():111-6. PubMed ID: 6983690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.